References

  1. Levêque D, Lemachatti J, Nivoix Y, Coliat P, Santucci R, Ubeaud-Séquier G, Beretz L, Vinzio S. Mécanismes des interactions médicamenteuses d'origine pharmacocinétique. Rev Med Interne. 2010; 31(2): 170-179. Google Scholar

  2. Scheen André. Interactions médicamenteuses: de la théorie à la pratique. Rev Méd Liège. 2006; 61(5-6): 471-82. Google Scholar

  3. Doucet J, Jego A, Noel D, Geffroy CE, Capet C, Coquard A, Couffin E, Fauchais AL, Chassagne P, Mouton-Schleifer D, Bercoff E. Preventable and non-preventable risk factors for adverse drug events related to hospital admissions in the elderly. Clin Drug Investig. 2002; 22(6): 385-392. Google Scholar

  4. Ibanez A, Alcala M, Garcia J, Puche E. Drug-drug interactions in patients from an internal medicine service. Farm Hosp. 2008; 32(5): 293-7. PubMed | Google Scholar

  5. Yach D, Hawkes C, Gould CL, Hofman KJ. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA. 2004; 291(21): 2616-2622. PubMed | Google Scholar

  6. Labetoulle M. La iatrogénie: quelle ampleur, pourquoi et comment la réduire. J Fr Ophtalmol. 2009; 32(1): 79-82. Google Scholar

  7. Faculté de Pharmacie de Monastir. Guide de stage d'internat Pharmacie hospitalière et clinique 6eme. année pharmacie. 2012/2013. Google Scholar

  8. Thériaque. Bienvenue sur banque de donnée sur les médicaments Thériaque. Accessed on 08 June 2017.

  9. Agence française de sécurité sanitaire des produits de santé. Thesaurus: Référentiel national des interactions médicamenteuses. Accessed on 08 June 2017.

  10. World Health Organization ATC/DDD Index 2017. WHO collaborating centre for drug statistics methodology. Accessed on 08 June 2017.

  11. Patel VK, Acharya LD, Rajakannan T, Surulivelrajan M, Guddattu V, Padmakumar R. Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital. AMJ. 2011; 4(1): 9-14. PubMed | Google Scholar

  12. Vonbach P, Dubied A, Krähenbühl S, Beer JH. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine. EFIM. 2008; 19(6): 413-420. PubMed | Google Scholar

  13. Aparasu R, Baer R, Aparasu A. Clinically important potential drug-drug interactions in outpatient settings. RSAP. 2007; 3(4): 426-437. PubMed | Google Scholar

  14. Sharma S, Chhetri HP, Alam K. A study of potential drug-drug interactions among hospitalized cardiac patients in a teaching hospital in Western Nepal. IJP. 2014; 46(2): 152. PubMed | Google Scholar

  15. Riechelmann RP, Moreira F, Smaletz O, Saad ED. Potential for drug interactions in hospitalized cancer patients. Cancer Chemother Pharmacol. 2005; 56(3): 286-290. PubMed | Google Scholar

  16. Doubova SV, Reyes-Morales H, Torres-Arreola Ldel P, Suarez- Orteg M. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC Health Serv Res. 2007; 7: 147. PubMed | Google Scholar

  17. Bjorkman IK, Fastbom J, Schmidt IK, Bernsten CB. Drug-drug interactions in the elderly. Ann Pharmacother. 2002; 36(11): 1675-81. PubMed | Google Scholar

  18. Nightingle PG, Adu D, Richards NT, Peters M. Implementation of rules based computerized bedside prescribing and administration: Intervention study. BMJ. 2000; 320: 750. Google Scholar

  19. Smithburger PL, Kane-Gill SL, Seybert AL. Drug-drug interactions in cardiac and cardiothoracic intensive care units. Drug Saf. 2010; 33(10): 879-888. PubMed | Google Scholar